As Resmed INC (RMD) Shares Rose, Voloridge Investment Management LLC Has Decreased Its Position by $3.36 Million

ResMed Inc. (NYSE:RMD) LogoInvestors sentiment increased to 1 in Q2 2019. Its up 0.03, from 0.97 in 2019Q1. It improved, as 29 investors sold RMD shares while 137 reduced holdings. 52 funds opened positions while 114 raised stakes. 93.37 million shares or 0.85% less from 94.17 million shares in 2019Q1 were reported. First Mercantile Trust holds 0.09% of its portfolio in ResMed Inc. (NYSE:RMD) for 6,936 shares. Fdx Advisors has 0.03% invested in ResMed Inc. (NYSE:RMD) for 5,917 shares. Century holds 0.09% of its portfolio in ResMed Inc. (NYSE:RMD) for 750,904 shares. First Hawaiian State Bank holds 2,493 shares. Ima Wealth invested in 0% or 26 shares. Geode Cap Ltd Liability reported 0.06% of its portfolio in ResMed Inc. (NYSE:RMD). Deutsche Bancshares Ag holds 0.04% in ResMed Inc. (NYSE:RMD) or 617,615 shares. Rnc Capital Ltd Liability Corp has invested 0.02% of its portfolio in ResMed Inc. (NYSE:RMD). Cipher Cap Lp accumulated 3,016 shares. Washington Mgmt reported 4,000 shares. Ftb Advsrs invested 0% in ResMed Inc. (NYSE:RMD). Westpac Banking has invested 0% in ResMed Inc. (NYSE:RMD). Chatham Capital Grp Inc reported 0.07% of its portfolio in ResMed Inc. (NYSE:RMD). Csat Advisory Lp invested in 388 shares. Copeland Capital Mngmt Ltd Llc holds 0.61% or 89,028 shares.

Voloridge Investment Management Llc decreased its stake in Resmed Inc (RMD) by 78.4% based on its latest 2019Q2 regulatory filing with the SEC. Voloridge Investment Management Llc sold 27,509 shares as the company’s stock rose 23.22% . The institutional investor held 7,578 shares of the medical and dental instruments company at the end of 2019Q2, valued at $925,000, down from 35,087 at the end of the previous reported quarter. Voloridge Investment Management Llc who had been investing in Resmed Inc for a number of months, seems to be less bullish one the $18.99 billion market cap company. The stock decreased 1.32% or $1.77 during the last trading session, reaching $132.19. About 606,172 shares traded or 16.92% up from the average. ResMed Inc. (NYSE:RMD) has risen 22.98% since September 13, 2018 and is uptrending. It has outperformed by 22.98% the S&P500.

Voloridge Investment Management Llc, which manages about $1.43B and $3.62 billion US Long portfolio, upped its stake in Halliburton Co (NYSE:HAL) by 207,743 shares to 799,521 shares, valued at $18.18 million in 2019Q2, according to the filing. It also increased its holding in Colgate Palmolive Co (NYSE:CL) by 54,992 shares in the quarter, for a total of 73,485 shares, and has risen its stake in International Flavors&Fragra (NYSE:IFF).

Analysts await ResMed Inc. (NYSE:RMD) to report earnings on October, 24. They expect $0.84 EPS, up 3.70 % or $0.03 from last year’s $0.81 per share. RMD’s profit will be $120.68M for 39.34 P/E if the $0.84 EPS becomes a reality. After $0.95 actual EPS reported by ResMed Inc. for the previous quarter, Wall Street now forecasts -11.58 % negative EPS growth.

More notable recent ResMed Inc. (NYSE:RMD) news were published by: Finance.Yahoo.com which released: “Is Resmed a Buy? – Yahoo Finance” on August 19, 2019, also Finance.Yahoo.com with their article: “Here’s What Hedge Funds Think About ResMed Inc. (RMD) – Yahoo Finance” published on June 18, 2019, Finance.Yahoo.com published: “Why We Like ResMed Inc.’s (NYSE:RMD) 17% Return On Capital Employed – Yahoo Finance” on June 14, 2019. More interesting news about ResMed Inc. (NYSE:RMD) were released by: Finance.Yahoo.com and their article: “The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication – Yahoo Finance” published on September 06, 2019 as well as Seekingalpha.com‘s news article titled: “ResMed declares $0.39 dividend – Seeking Alpha” with publication date: July 25, 2019.

ResMed Inc. (NYSE:RMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.